Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Sphingosine Kinase Inhibition Has Pre-Clinical Activity in Acute Lymphoblastic Leukemia,

Craig T. Wallington-Beddoe, BSc, MBBS, David Ho, BSc, Kenneth Francis Bradstock, MB, PhD, Linda J. Bendall, BSc, PhD

Blood (2011) 118 (21): 3573.

https://doi.org/10.1182/blood.V118.21.3573.3573

Published: 2011

Journal Articles

Application of Dual PI-3K/mTOR Inhibitors Is Not Always Superior to Inhibition of mTOR Alone.,

Jacky Wong, BSc, Robert Welschinger, BSc, PhD, Rana Baraz, BMedSc, Kenneth Francis Bradstock, MB, PhD, Linda J. Bendall, BSc, PhD

Blood (2011) 118 (21): 3575.

https://doi.org/10.1182/blood.V118.21.3575.3575

Published: 2011

Journal Articles

Comparison Between the International Standardised Approach and a Single Tube Ten Colour Flow Cytometric Assay for Detection of Minimal Residual Disease in CLL

Mary M Sartor, BSc, MSc, Kenneth Francis Bradstock, MB, PhD, FRACP, FRCPA, David Gottlieb, MB

Blood (2011) 118 (21): 1460.

https://doi.org/10.1182/blood.V118.21.1460.1460

Published: 2011

Journal Articles

ALL Cells Mobilized by AMD3100 Are More Proliferative, and Remain In the Circulation Longer Than Normal HSC, Enhancing the Action of Vincristine

Linda J. Bendall, BSc, PhD, Robert Welschinger, BSc, PhD, Florian Liedtke, Carole Ford, BSc, PhD, Aileen Dela Pena, BSc, PhD, Julius G Juarez, BSc, PhD, Kenneth Francis Bradstock, MB, PhD

Blood (2010) 116 (21): 2137.

https://doi.org/10.1182/blood.V116.21.2137.2137

Published: 2010

Journal Articles

S1P 1 Agonists for Use as Adjunct Mobilizing Agents

Nadia Harun, BSc, (Hons), PhD, Marilyn Thien, BSc, (Hons), PhD, Julius G Juarez, BSc(Hons), PhD, Kenneth Francis Bradstock, MB, PhD, Linda J. Bendall, BSc, PhD

Blood (2010) 116 (21): 826.

https://doi.org/10.1182/blood.V116.21.826.826

Published: 2010

Journal Articles

FTY720 Has Potent Anti-Leukemic Effects on Acute Lymphoblastic Leukemia Cells and Results In Caspase Independent Cell Death

Craig T. Wallington-Beddoe, BSc, MBBS, John Hewson, MBBS, Kenneth Francis Bradstock, MB, PhD, Linda J. Bendall, BSc, PhD

Blood (2010) 116 (21): 3260.

https://doi.org/10.1182/blood.V116.21.3260.3260

Published: 2010

NARROW

Sphingosine Kinase Inhibition Has Pre-Clinical Activity in Acute Lymphoblastic Leukemia,

Application of Dual PI-3K/mTOR Inhibitors Is Not Always Superior to Inhibition of mTOR Alone.,

Comparison Between the International Standardised Approach and a Single Tube Ten Colour Flow Cytometric Assay for Detection of Minimal Residual Disease in CLL

ALL Cells Mobilized by AMD3100 Are More Proliferative, and Remain In the Circulation Longer Than Normal HSC, Enhancing the Action of Vincristine

S1P 1 Agonists for Use as Adjunct Mobilizing Agents

FTY720 Has Potent Anti-Leukemic Effects on Acute Lymphoblastic Leukemia Cells and Results In Caspase Independent Cell Death

Email alerts

ASH Publications

American Society of Hematology

Sphingosine Kinase Inhibition Has Pre-Clinical Activity in Acute Lymphoblastic Leukemia,

Application of Dual PI-3K/mTOR Inhibitors Is Not Always Superior to Inhibition of mTOR Alone.,

Comparison Between the International Standardised Approach and a Single Tube Ten Colour Flow Cytometric Assay for Detection of Minimal Residual Disease in CLL

ALL Cells Mobilized by AMD3100 Are More Proliferative, and Remain In the Circulation Longer Than Normal HSC, Enhancing the Action of Vincristine

S1P 1 Agonists for Use as Adjunct Mobilizing Agents

FTY720 Has Potent Anti-Leukemic Effects on Acute Lymphoblastic Leukemia Cells and Results In Caspase Independent Cell Death

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only